145 related articles for article (PubMed ID: 3401588)
1. A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course.
Swolin B; Weinfeld A; Westin J
Blood; 1988 Aug; 72(2):386-95. PubMed ID: 3401588
[TBL] [Abstract][Full Text] [Related]
2. Chromosome studies in 104 patients with polycythemia vera.
Diez-Martin JL; Graham DL; Petitt RM; Dewald GW
Mayo Clin Proc; 1991 Mar; 66(3):287-99. PubMed ID: 2002687
[TBL] [Abstract][Full Text] [Related]
3. The pattern and clinical significance of karyotypic abnormalities in patients with idiopathic and postpolycythemic myelofibrosis.
Miller JB; Testa JR; Lindgren V; Rowley JD
Cancer; 1985 Feb; 55(3):582-91. PubMed ID: 3965109
[TBL] [Abstract][Full Text] [Related]
4. A chromosomal profile of polycythemia vera.
Rege-Cambrin G; Mecucci C; Tricot G; Michaux JL; Louwagie A; Van Hove W; Francart H; Van den Berghe H
Cancer Genet Cytogenet; 1987 Apr; 25(2):233-45. PubMed ID: 3828970
[TBL] [Abstract][Full Text] [Related]
5. [Karyotype studies in primary polycythemia vera (author's transl)].
Berger R; Parmentier C; Droz JP
Nouv Rev Fr Hematol; 1974; 14(6):705-12. PubMed ID: 4282500
[No Abstract] [Full Text] [Related]
6. Cytogenetic studies on acute nonlymphocytic leukemias following polycythemia vera.
Berger R; Bernheim A; Flandrin G; Dresch C; Najean Y
Cancer Genet Cytogenet; 1984 Apr; 11(4):441-51. PubMed ID: 6704942
[TBL] [Abstract][Full Text] [Related]
7. Trisomy 1q in polycythemia vera and its relation to disease transition.
Swolin B; Weinfeld A; Westin J
Am J Hematol; 1986 Jun; 22(2):155-67. PubMed ID: 3706291
[TBL] [Abstract][Full Text] [Related]
8. [Cytogenetics and molecular genetics in myelofibrosis with myeloid metaplasia and polycythemia vera].
Roche-Lestienne C; Andrieux J
Pathol Biol (Paris); 2007 Feb; 55(1):49-55. PubMed ID: 16901657
[TBL] [Abstract][Full Text] [Related]
9. Karyotype and molecular cytogenetic studies in polycythemia vera.
Andrieux JL; Demory JL
Curr Hematol Rep; 2005 May; 4(3):224-9. PubMed ID: 15865876
[TBL] [Abstract][Full Text] [Related]
10. Karyotypic abnormalities in myelofibrosis following polycythemia vera.
Andrieux J; Demory JL; Caulier MT; Agape P; Wetterwald M; Bauters F; Laï JL
Cancer Genet Cytogenet; 2003 Jan; 140(2):118-23. PubMed ID: 12645649
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic studies in polycythemia vera.
Jarosová M; Indrák K; Dusek J; Kapustová M
Neoplasma; 1988; 35(2):221-8. PubMed ID: 3374710
[TBL] [Abstract][Full Text] [Related]
12. Acute lymphoblastic leukemia in a patient with longstanding polycythemia vera: cytogenetic analysis reveals two distinct abnormal clones.
Anastasi J; Pettenati MJ; Le Beau MM; Kwaan HC; Weil SC
Am J Hematol; 1988 Sep; 29(1):33-7. PubMed ID: 3177367
[TBL] [Abstract][Full Text] [Related]
13. Karyotypic patterns and their clinical significance in polycythemia vera.
Testa JR; Kanofsky JR; Rowley JD; Baron JM; Vardiman JW
Am J Hematol; 1981; 11(1):29-45. PubMed ID: 6943932
[TBL] [Abstract][Full Text] [Related]
14. Abnormalities of chromosome 1 in myeloproliferative disorders.
Rowley JD
Cancer; 1975 Nov; 36(5):1748-57. PubMed ID: 1192363
[TBL] [Abstract][Full Text] [Related]
15. Inter-relationship between polycythaemia vera, leukaemia and myeloid metaplasia.
Modan B
Clin Haematol; 1975 Jun; 4(2):427-39. PubMed ID: 1102196
[No Abstract] [Full Text] [Related]
16. Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.
Michiels JJ; Kutti J; Stark P; Bazzan M; Gugliotta L; Marchioli R; Griesshammer M; van Genderen PJ; Brière J; Kiladjian JJ; Barbui T; Finazzi G; Berlin NI; Pearson TC; Green AC; Fruchtmann SM; Silver RT; Hansmann E; Wehmeier A; Lengfelder E; Landolfi R; Kvasnicka HM; Hasselbalch H; Cervantes F; Thiele J
Neth J Med; 1999 Feb; 54(2):46-62. PubMed ID: 10079679
[TBL] [Abstract][Full Text] [Related]
17. Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature.
Swolin B; Rödjer S; Westin J
Ann Hematol; 2008 Jun; 87(6):467-74. PubMed ID: 18351338
[TBL] [Abstract][Full Text] [Related]
18. Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosis.
Dingli D; Schwager SM; Mesa RA; Li CY; Dewald GW; Tefferi A
Cancer; 2006 May; 106(9):1985-9. PubMed ID: 16568439
[TBL] [Abstract][Full Text] [Related]
19. Post-polycythemia myeloid metaplasia: experience with a large cohort of patients.
Randi ML; Barbone E; Fabris F; Varotto L; Macri C; Girolami A
J Med; 1994; 25(6):363-9. PubMed ID: 7769374
[TBL] [Abstract][Full Text] [Related]
20. Increased likelihood of post-polycythemia vera myelofibrosis in Ph-negative MPN patients with chromosome 12 abnormalities.
Benton CB; Tanaka M; Wilson C; Pierce S; Zhou L; Cortes J; Kantarjian H; Verstovsek S
Leuk Res; 2015 Apr; 39(4):419-23. PubMed ID: 25687833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
